ArticleScientific reports2025
Integrated bioinformatics analysis of biomarkers and pathways to explore the mechanisms and molecular targets related to allergic rhinitis and pyroptosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gene screening and immune phenotype shifts of osteoporosis.Scientific reports · 2026Article
- The role of NEDD4-mediated ubiquitination of AQP5 in allergic rhinitis: implications for nasal mucosal barrier function.Frontiers in immunology · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergic rhinitis (AR) is a condition with a rising global prevalence, though its specific pathogenic mechanisms remain elusive. Several studies have indicated that pyroptosis is one of the key mechanisms in the pathogenesis of AR. However, no research has investigated the molecular targets of pyroptosis in the context of AR. Our study endeavored to identify common biomarkers and mechanisms that could offer insights into the prevention of AR progression and novel therapeutic targets. Data from the Gene Expression Omnibus (GEO) database, including GSE51392, GSE43523, and GSE44037, were downloaded and analyzed through weighted gene co-expression network analysis (WGCNA), Least Absolute Shrinkage and Selection Operator (LASSO), and random forest (RF) analysis to identify key intersecting genes associated with both AR and pyroptosis. The gene GZMA was identified as a significant candidate and was validated in another sample dataset (GSE101720). Western blot (WB) analysis confirmed the expression of GZMA in an AR mouse model. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were conducted to explore the functional roles of the shared genes. An immune infiltration matrix was established using CIBERSORT analysis to estimate the degree of immune cell infiltration in AR. Single-sample Gene Set Enrichment Analysis (ssGSEA) was performed to analyze the biological functions of hub genes. In the immune infiltration matrix of AR, a reduced expression of Tregs was observed in the AR group. WB analysis further indicated elevated expression of GZMA in the AR group. As a gene related to both AR and pyroptosis, GZMA expression was positively correlated with the gene expression levels of CD8 + T cells. The reduction in Tregs and the increase in CD8 + T cells in AR, along with enhanced pyroptosis, contribute to the development of allergic inflammation. Therefore, it was hypothesized that GZMA could serve as a novel target for the prevention and treatment of AR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.